Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine
ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of
treatment for chronic dry eye disease